ES2038659T3 - Composicion farmaceutica antimicrobiana topica que comprende un compuesto de plata y un azol. - Google Patents

Composicion farmaceutica antimicrobiana topica que comprende un compuesto de plata y un azol.

Info

Publication number
ES2038659T3
ES2038659T3 ES198787302490T ES87302490T ES2038659T3 ES 2038659 T3 ES2038659 T3 ES 2038659T3 ES 198787302490 T ES198787302490 T ES 198787302490T ES 87302490 T ES87302490 T ES 87302490T ES 2038659 T3 ES2038659 T3 ES 2038659T3
Authority
ES
Spain
Prior art keywords
compositions
treatment
silver compound
azol
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787302490T
Other languages
English (en)
Inventor
Linda Mary Edwards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew PLC
Original Assignee
Smith and Nephew PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith and Nephew PLC filed Critical Smith and Nephew PLC
Application granted granted Critical
Publication of ES2038659T3 publication Critical patent/ES2038659T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES FARMACOLOGICAS QUE SON ADECUADAS PARA APLICACION TOPICA EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS Y/O MICOTICAS. LAS COMPOSICIONES CONTIENEN UNA MEZCLA SINERGICA DE UN COMPUESTO DE PLATA Y UN DERIVADO DE AZOL JUNTO CON UN PORTADOR FARMACOLOGICAMENTE ACEPTABLE PARA ELLOS. LAS COMPOSICIONES PUEDEN APLICARSE TOPICAMENTE EN EL TRATAMIENTO DE ULCERAS DE QUEMADURAS Y OTRAS LESIONES DE LA PIEL, INFECCIONES GENERALES DE LA PIEL Y TAMBIEN EN EL TRATAMIENTO DE INFECCIONES DE LAS MUCOSAS. SON PREFERIBLES LAS COMPOSICIONES QUE CONTIENEN SULFADIAZINA DE PLATA Y CLOTRIMAZOL O METRONIDAZOL. LAS COMPOSICIONES PUEDEN APLICARSE COMO UNGUENTOS, GELES, PESARIOS, TABLETAS Y SIMILARES.
ES198787302490T 1986-03-22 1987-03-23 Composicion farmaceutica antimicrobiana topica que comprende un compuesto de plata y un azol. Expired - Lifetime ES2038659T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868607159A GB8607159D0 (en) 1986-03-22 1986-03-22 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ES2038659T3 true ES2038659T3 (es) 1993-08-01

Family

ID=10595080

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787302490T Expired - Lifetime ES2038659T3 (es) 1986-03-22 1987-03-23 Composicion farmaceutica antimicrobiana topica que comprende un compuesto de plata y un azol.

Country Status (10)

Country Link
US (1) US4803066A (es)
EP (1) EP0241175B1 (es)
JP (1) JPS62252725A (es)
AT (1) ATE59297T1 (es)
AU (1) AU590060B2 (es)
CA (1) CA1280366C (es)
DE (1) DE3767003D1 (es)
ES (1) ES2038659T3 (es)
GB (1) GB8607159D0 (es)
ZA (1) ZA872120B (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
JPH0818983B2 (ja) * 1987-12-08 1996-02-28 塩野義製薬株式会社 水虫治療剤
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
CA1337279C (en) * 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
ZA939117B (en) * 1992-12-04 1994-08-05 Susanna Elizabeth Chalmers Pharmaceutical product
US5370876A (en) * 1993-01-08 1994-12-06 Microbarriers Antimicrobial protective skin composition and method for protecting skin from body fluids
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
HU215443B (hu) * 1994-07-25 1999-04-28 Márton Milánkovits Többféle hatóanyagot tartalmazó gyógyszerkészítmények, főként hüvelykúp, baktericid, fungicid, protozoa- és vírusellenes kombinált hatással
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
KR20010012464A (ko) 1997-05-12 2001-02-15 세이지 파마슈티칼스, 인크. 화상 치료 및 감염 방지를 위한 국소 분무
WO1999004829A1 (en) 1997-07-28 1999-02-04 Redmond Mary L Composition and process for the treatment of epidermal traumas such as decubitus ulcers
US20030147925A1 (en) * 1998-09-11 2003-08-07 Samuel P. Sawan Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same
US6582683B2 (en) 2000-01-04 2003-06-24 Skinvisible Pharmaceuticals, Inc. Dermal barrier composition
US7137968B1 (en) * 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
WO2001074300A1 (en) * 2000-03-30 2001-10-11 Brennen Medical, Inc. Anti-microbial and immunostimulating composition
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US7427416B2 (en) * 2000-07-27 2008-09-23 Nucryst Pharmaceuticals Corp. Methods of treating conditions using metal-containing materials
US7001617B2 (en) 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
US7255881B2 (en) * 2000-07-27 2007-08-14 Nucryst Pharmaceuticals Corp. Metal-containing materials
WO2002009729A2 (en) 2000-07-27 2002-02-07 Nucryst Pharmaceuticals Corp. Treatment of hyperproliferative skin disorders and diseases
US20030206966A1 (en) * 2000-07-27 2003-11-06 Burrell Robert E. Methods of inducing apoptosis and modulating metalloproteinases
US20030185901A1 (en) 2000-07-27 2003-10-02 Burrell Robert E. Methods of treating conditions with a metal-containing material
US20030180379A1 (en) * 2000-07-27 2003-09-25 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US7008647B2 (en) 2001-04-23 2006-03-07 Nucryst Pharmaceuticals Corp. Treatment of acne
US20040191329A1 (en) * 2000-07-27 2004-09-30 Burrell Robert E. Compositions and methods of metal-containing materials
US6399092B1 (en) 2000-12-27 2002-06-04 Healthpoint, Ltd. Anhydrous, hydrophilic absorbent wound dressing (tube) with antimicrobials or other pharmaceutically active agents
AU2002303438B2 (en) 2001-04-23 2007-10-25 Smith & Nephew (Overseas) Limited Therapeutic treatments using the direct application of antimicrobial metal compositions
US6756059B2 (en) * 2001-08-20 2004-06-29 Skinvisible Pharmaceuticals, Inc. Topical composition, topical composition precursor, and methods for manufacturing and using
US7201925B2 (en) * 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
AU2003286575A1 (en) * 2002-10-22 2004-05-13 Nucryst Pharmaceuticals Corp. Prophylactic treatment methods
US20040126339A1 (en) * 2002-12-31 2004-07-01 Roszell James A. Sunscreen composition and methods for manufacturing and using a sunscreen composition
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
BRPI0414500A (pt) * 2003-09-19 2006-11-07 Drugtech Corp formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
AU2006244260A1 (en) * 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
US8481049B2 (en) * 2005-05-27 2013-07-09 Bharat Biotech International Limited Methods for treating a wound using epidermal growth factor formulation
CA2635994A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
EA200870153A1 (ru) * 2006-01-05 2008-12-30 Драгтек Корпорейшн Композиция и способ ее использования
US20080044491A1 (en) * 2006-06-30 2008-02-21 Nucryst Pharmaceuticals Metal-containing formulations and methods of use
WO2008066618A2 (en) * 2006-10-20 2008-06-05 Skinvisible Pharmaceuticals, Inc. Antifungal composition and methods for using
US8128913B1 (en) 2007-12-06 2012-03-06 Skinvisible Pharmaceuticals, Inc. Sunscreen composition with enhanced UV-A absorber stability and methods
WO2009085651A1 (en) * 2007-12-20 2009-07-09 Nucryst Pharmaceuticals Corp. Metal carbonate particles for use in medicine and methods of making thereof
US8299122B2 (en) * 2008-04-14 2012-10-30 Skinvisible Pharmaceuticals, Inc. Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition
FR2978664B1 (fr) 2011-08-04 2014-01-10 Petcare Innovation Composition antiseptique
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
PL411078A1 (pl) * 2015-01-27 2016-08-01 Uniwersytet Medyczny w Łodzi Związek kompleksowy srebra, sposób wytwarzania związku kompleksowego oraz zastosowanie związku kompleksowego
CA3074150A1 (en) 2020-02-18 2021-08-18 Ovation Science, Inc. Composition and method for transdermal delivery of cannabidiol (cbd) and delta9-tetrahydrocannabinol (thc)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2319852A1 (de) * 1972-04-21 1973-10-25 Biological Concepts Inc Verfahren zur herstellung einer zur aufnahme von arzneimitteln geeigneten, saugfaehigen fasermasse aus protein, insbesondere aus kollagen
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
GB2108517B (en) * 1981-06-12 1985-06-12 Nat Res Dev Hydrogels
FR2558058B1 (fr) * 1984-01-18 1987-03-20 Pf Medicament Compositions dermatologiques a usage topique externe, a base de metronidazole utiles pour le traitement de l'acne
US4636520A (en) * 1984-07-16 1987-01-13 Fujisawa Pharmaceutical Co., Ltd. Antifungal composition employing pyrrolnitrin in combination with an imidazole compound

Also Published As

Publication number Publication date
ZA872120B (en) 1987-10-28
EP0241175A1 (en) 1987-10-14
US4803066A (en) 1989-02-07
ATE59297T1 (de) 1991-01-15
GB8607159D0 (en) 1986-04-30
AU590060B2 (en) 1989-10-26
AU7054387A (en) 1987-09-24
EP0241175B1 (en) 1990-12-27
JPS62252725A (ja) 1987-11-04
DE3767003D1 (de) 1991-02-07
CA1280366C (en) 1991-02-19

Similar Documents

Publication Publication Date Title
ES2038659T3 (es) Composicion farmaceutica antimicrobiana topica que comprende un compuesto de plata y un azol.
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
MY102101A (en) Pharmaceutical gel composition
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
AU6194694A (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
DE69332204T2 (de) Minocyclin und EDTA enthaltende Beschichtungszusammensetzung für Medizinische Geräte
EP0142426A3 (en) Ophthalmic formulation containing norfloxacin and related antibiotics
AU6825300A (en) Compounds
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
WO1995017165A3 (en) Tissue moisturizing and antimicrobial compositions
AU3887797A (en) Pentafluorobenzenesulfonamides and analogs
PT806941E (pt) Composicoes anti-bacterianas liposomicas de rigidez baixa
CA2201477A1 (en) New pyrimidone derivatives with antifungal activity
AU2745700A (en) A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
IE863104L (en) Quinolone derivatives
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
TR199802769T2 (xx) Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim.
WO2000040583A3 (de) Imidazo[4,5-c]-pyridin-4-on-derivate
CA2267309A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
IE44070L (en) Polyamines.
AU7865791A (en) Anti-actinic agent
AU3435189A (en) Topically applied gold organic complex
CA2003213A1 (en) Antimycotically active cyclopropyl-substituted azolylmethylcarbinols
ES2128353T3 (es) Composicion topica que contiene penciclovir.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 241175

Country of ref document: ES